Topics Webinar | The Role of Transmembrane Mucins in Lung Diseases
Topics Webinar | The Role of Transmembrane Mucins in Lung Diseases
Part of the MDPI Topics Webinars series
Mucins, Interstitial lung diseases, COVID19, rheumatology diseases associated with pulmonary involvement, Lung Cancer
Welcome from the Chairs
Topics Webinar
The Role of Transmembrane Mucins in Lung Diseases
Dear all, thank you for the participation to the webinar that allow to prompt our Topic “The role of transmembrane mucins in lung diseases” published in MDPI journals list: Cancers, Biology, IJERPH, current oncology and Diseases.
Recently, there has been growing interest in the investigation of the diagnostic and prognostic role of mucins in different lung diseases, including interstitial lung disease, lung cancer and COVID-19.
This has highlighted the role of transmembrane mucins in rheumatologic disorders associated with ILD and the need to identify patients with lung involvement because of the inexorably worsening condition of patients with concomitant interstitial lung involvement. Moreover, since the outbreak of the severe acute respiratory syndrome coronavirus-2 pandemic, the usefulness of mucins for monitoring disease severity has been suggested.
Today, I’m glad to introduce two colleagues of mine: Prof. Ornella Piazza from University of Salerno, whom major research area is the clinical use of biomarkers in acute respiratory distress syndrome and COVID-19 and Dr Laura Bergantini from University of Siena, whom main research area is the investigation of mucins as diagnostic and prognostic marker for ILD associated and non-associated with rheumatologic disorders.
Date: 28 April 2022
Time: 3:00pm CEST | 9:00am EDT | 9:00pm CST Asia
Webinar ID: 820 1650 8128
Webinar Secretariat: topics.webinar@mdpi.com
Chair
Respiratory diseases Unit, Department of medical and surgical sciences & neurosciences, University of Siena, Italy
Dr. Miriana d’Alessandro, is currently PhD student in Genetics, Oncology and Clinical Medicine (GenOMeC) at the laboratory of Respiratory Diseases, University of Siena She received a Bachelor Degree in Laboratory Technician and Master of Science in Health Biology. She published several manuscripts about biomarkers in different different diffuse lung diseases including connective tissue disease-associated interstitial lung diseases (ILD), idiopathic interstitial pneumonias (IIPs), pulmonary sarcoidosis and hypersensitivity pneumonitis (HP), Pulmonary Langerhans’ cell histiocytosis (PLCH) and lymphangioleyomyomatosis (LAM). Her main research interest has focused on molecular and cellular biology, immunoassays, cytofluorimetric analysis, characterization of extracellular vesicles in the fluids of patients with interstitial lung diseases (ILD). The goal of research activity is the validation and study of novel biomarkers for predicting prognosis and response to therapy in patients affected by fibrotic and non-fibrotic ILD.
Invited Speakers
Prof. Dr. Ornella Piazza is associate professor at the Department of Medicine and Surgery at Salerno University. Prof. Dr. Piazza with her colleagues has started the Centre for Translational Science of the University of Salerno (CeTIS). She is editor of the open access journal TranslationalMedicine@UniSa (www.translationalmedicine.unisa.it). The clinical use of biomarkers of brain injury, acute respiratory distress syndrome and COVID-19 is the major research area of Prof. Piazza.
Respiratory Diseases Unit, Department of Medical and Surgical Sciences & Neurosciences, University of Siena, Italy
Dr. Laura Bergantini is currently junior researchers at the laboratory of Respiratory Diseases, University of Siena. She received a Bachelor Degree in Biotechnology and Master of Science in Medical Biotechnology with honors. She published several manuscripts about biomarkers in different diffuse lung diseases including, idiopathic interstitial pneumonias (IIPs), sarcoidosis and hypersensitivity pneumonitis (HP), lung transplantation and COVID-19. Today, her main research interests deal with the immunology of lung disorders through cytofluorimetric approach.
Webinar content
Registration
This is a FREE webinar. The number of participants to the live session is limited but the recording will be made available on Sciforum shortly afterwards. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Program
|
Speaker/Presentation |
Time in CEST |
|
Dr. Miriana d'Alessandro Introduction |
3:00pm-3:30pm |
|
Prof. Dr. Ornella Piazza The Usefulness of Mucins in ARDS and COVID-19 Patients and Their Potential as Disease Severity Markers |
3:30pm-4:00pm |
|
Dr. Laura Bergantini Mucins as Diagnostic and Prognostic Marker of Interstitial Lung Diseases Patients |
4:00pm-4:30pm |
|
Q&A Session |
4:30pm-5:00pm |
|
Closing of Webinar Dr. Miriana d'Alessandro |
5:00pm |
Relevant Topics
The Role of Transmembrane Mucins in Lung Diseases
Topic Editors: Dr. Miriana D’Alessandro, Dr. Edoardo Conticini, Dr. Elena Bargagli, Dr. Lucia Vietri, Dr. Laura Bergantini & Dr. Donato Lacedonia
Deadline for abstract submissions: 30 August 2022
Deadline for manuscript submissions: 31 October 2022
Sponsors and Partners
Organizers
